Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 May 24 424B3 Prospectus supplement
- 3 Oct 22 424B4 Prospectus supplement with pricing info
- 30 Sep 22 EFFECT Notice of effectiveness
-
2 Sep 22 S-1/A IPO registration (amended)
- 19 Aug 22 S-1 IPO registration
PBLA similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 and related prospectus of our report dated March 22, 2022, with respect to the consolidated financial statements of CPP Pharmaceuticals, Inc. (Company) as of December 31, 2021 and 2020 and for the two years then ended (which report includes an explanatory paragraph regarding the existence of substantial doubt about the Company’s ability to continue as a going concern), and to the reference to us under the heading “Experts” in the prospectus which is part of this Registration Statement.
/s/ Mayer Hoffman McCann P.C.
San Diego, CA
September 2, 2022